輸入代號或公司名稱後按 Enter
4121

優盛

+0.05 (+0.40%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
12.7020成交張數本益比0.74股價淨值比0.00%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q2-0.21-0.50-0.16-1.7%-1.19%-2.87%
2026Q1-0.11-0.35-0.09-1.0%-0.66%-2.01%
2025Q4-0.09-0.36-0.07-0.7%-0.47%-2.07%
2025Q3-0.09-0.42-0.08-0.8%-0.56%-2.51%
2025Q2-0.06-0.48-0.05-0.5%-0.35%-2.81%
2025Q1-0.12-400.0%-0.50-0.10-1.1%-0.69%-2.85%
2024Q4-0.15-0.34-0.13-1.4%-0.89%-2.01%
2024Q3-0.15-400.0%-0.41-0.12-1.3%-0.82%-2.30%
2024Q2-0.08-0.21-0.07-0.8%-0.47%-1.23%
2024Q10.04-63.6%-0.150.040.4%0.24%-0.81%
2023Q4-0.22-178.6%-0.08-0.18-1.9%-1.25%-0.44%
2023Q30.05-91.1%0.420.040.4%0.25%2.35%
2023Q2-0.02-102.1%0.93-0.02-0.2%-0.11%5.40%
2023Q10.11-50.0%1.900.091.0%0.61%10.61%
2022Q40.28600.0%2.010.242.2%1.53%11.36%
2022Q30.56250.0%1.770.474.4%3.18%10.23%
2022Q20.9517.3%1.370.816.3%5.50%7.95%
2022Q10.22-35.3%1.230.182.0%1.26%7.27%
2021Q40.04-91.3%1.350.050.4%0.33%7.99%
2021Q30.16-79.6%1.770.151.6%0.99%10.67%
2021Q20.81133.5%2.400.656.4%4.54%13.79%
2021Q10.3437.2%1.930.272.8%1.97%11.47%
2020Q40.46173.0%1.840.343.4%2.70%11.01%
2020Q30.791219.8%1.550.575.8%4.86%9.80%
2020Q20.35600.8%0.820.253.0%2.23%5.38%
2020Q10.25257.1%0.530.192.3%1.66%3.48%
2019Q40.170.350.121.6%1.09%2.30%
2019Q30.06-25.0%0.160.040.6%0.40%1.06%
2019Q20.05-70.6%0.180.040.5%0.35%1.20%
2019Q10.070.300.050.7%0.46%1.90%
2018Q4-0.02-116.6%0.23-0.02-0.2%-0.15%1.47%
2018Q30.08-77.8%0.370.060.8%0.54%2.38%
2018Q20.17-43.3%0.640.121.5%1.05%4.26%
2018Q10.000.770.000.0%0.03%5.16%
2017Q40.12-81.8%0.380.091.0%0.76%2.46%
2017Q30.360.910.273.2%2.39%6.19%
2017Q20.300.470.222.9%1.99%3.18%
2017Q1-0.40-0.05-0.29-4.2%-2.66%-0.30%
2016Q40.650.270.496.5%4.48%
2016Q3-0.09-0.07-0.9%-0.62%